Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ahmad Awada, MD, PhD, of the Jules Bordet Cancer Institute, Brussels, Belgium, explains the immunotherapy future that is on the horizon. Speaking at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Prof. Awada goes on to discuss the treatment of patients that are HIV-positive with checkpoint-inhibitors.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.